A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer

Oncology Nursing Forum

Volumn 34, Issue 5, 2007, Pages 997-1005

  Jansen, Catherine E ^a,b   Miaskowski, Christine A ^b   Dodd, Marilyn J ^b   Dowling, Glenna A ^b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; FEMALE; HUMAN; META ANALYSIS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TOXICITY AND INTOXICATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; HUMANS; NEUROPSYCHOLOGICAL TESTS; NEUROTOXICITY SYNDROMES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 35548949318     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/07.ONF.997-1005     Document Type: Article

References (35)

1. Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L.A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
2. Ahles, T.A., Tope, D.M., Furstenberg, C., Hann, D., & Mills, L. (1996). Psychological and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology, 14, 1457-1462.
3. Anderson-Hanley, C., Sherman, M.L., Riggs, R., Agocha, V.B., & Compas, B.E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society, 9, 967-982.
4. Bender, C.M., Sereika, S.M., Berga, S.L., Vogel, V.G., Brufsky, A.M., Paraska, K.K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430.
5. Brezden, C.B., Phillips, K.A., Abdolell, M., Bunston, T., & Tannock, I.F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
6. Castellon, S.A., Ganz, P.A., Bower, J.E., Petersen, L., Abraham, L., & Greendale, G.A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26, 955-969.
7. Chouinard, M.J., & Braun, C.M. (1993). A meta-analysis of the relative sensitivity of neuropsychological screening tests. Journal of Clinical and Experimental Neuropsychology, 15, 591-607.
8. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
9. Cole, R.P., Scialla, S.J., & Bednarz, L. (2000). Functional recovery in cancer rehabilitation. Archives of Physical Medicine and Rehabilitation, 81, 623-627.
10. Cull, A., Hay, C., Love, S.B., Mackie, M., Smets, E., & Stewart, M. (1996). What do cancer patients mean when they complain of concentration and memory problems? British Journal of Cancer, 74, 1674-1679.
11. Donovan, K.A., Small, B.J., Andrykowski, M.A., Schmitt, F.A., Munster, P., & Jacobsen, P.B. (2005). Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer, 104, 2499-2507.
12. Falleti, M.G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59(1), 60-70.
13. Freeman, J.R., & Broshek, D.K. (2002). Assessing cognitive dysfunction in breast cancer: What are the tools? Clinical Breast Cancer, 3(Suppl. 3), S91-S99.
14. Gazzaniga, M.S., Ivry, R.B., & Mangun, G.R. (2002). Cognitive neuroscience: The biology of the mind (2nd ed.). New York: Norton.
15. Glass, G.V. (1976). Primary, secondary, and meta-analysis of research. Educational Researcher, 5(10), 3-8.
16. Grober, S.E. (2002). Resources for treatment of chemotherapy-related cognitive difficulty. Cancer Practice, 10, 216-218.
17. Hedges, L.V., & Olkin, I. (1985). Statistical methods for meta-analysis. San Diego, CA: Academic Press.
18. Heilman, K.M., Valenstein, E., & Watson, R.T. (1997). Disorders of attention. In M.R. Trimble & J.L. Cummings (Eds.), Contemporary behavioral neurology (pp. 127-137). Boston: Butterworth-Heinemann.
19. Irwig, L., Tosteson, A.N., Gatsonis, C., Lau, J., Colditz, G., Chalmers, T.C., et al. (1994). Guidelines for meta-analyses evaluating diagnostic tests. Annals of Internal Medicine, 120, 667-676.
20. Johnson, B.T. (1993). DSTAT 1.10: Software for the meta-analytic review of research literature. Hillsdale, NJ: Lawrence Erlbaum.
21. Lezak, M.D., Howieson, D.B., & Loring, D.W. (2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.
22. Lipsey, M.W., & Wilson, D.B. (2001). Practical meta-analysis. London: Sage.
23. Raffa, R.B., Duong, P.V., Finney, J., Garber, D.A., Lam, L.M., Mathew, S.S., et al. (2006). Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy? Journal of Clinical Pharmacy and Therapeutics, 31, 129-138.
24. Schagen, S.B., van Dam, F.S., Muller, M.J., Boogerd, W., Lindeboom, J., & Bruning, P.F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
25. Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., et al. (2006). Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: Evaluation of long-term treatment effects. Annals of Oncology, 17, 415-423.
26. Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005). The effects of adjuvant chemotherapy on cognition in women with breast cancer - Preliminary results of an observational longitudinal study. Breast, 14, 142-150.
27. Shadish, W.R., & Haddock, C.K. (1994). Combining estimates of effect size. In H. Cooper & L.V. Hedges (Eds.). Handbook of research synthesis (pp. 261-282). New York: Russell Sage Foundation.
28. Spreen, O., & Strauss, E. (1998). A compendium of neuropsychological tests: Administration, norms, and commentary (2nd ed.). New York: Oxford University Press.
29. Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clinical Neuropsychologist, 20, 76-89.
30. Tchen, N., Juffs, H.G., Downie, F.P., Yi, Q.L., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183.
31. van Dam, F.S., Schagen, S.B., Muller, M.J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M.E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
32. Wefel, J.S., Lenzi, R., Theriault, R.L., Davis, R.N., & Meyers, C.A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer, 100, 2292-2299.
33. Wieneke, M.M., & Dienst, E.R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66.
34. Wolf, F.M. (1986). Meta-analysis. Sage University Paper Series on Quantitative Applications in the Social Sciences [Series no. 07-001]. Beverly Hills, CA: Sage.
35. Zakzanis, K.K. (2001). Statistics to tell the truth, the whole truth, and nothing but the truth: Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Archives of Clinical Neuropsychology, 16, 653-667.